ArticleBJC reports2025
Somatic DICER1 pathogenic variants detected in a well-differentiated fetal lung adenocarcinoma diagnosed in a man with familial adenomatous polyposis.
Article in BJC reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Well-differentiated fetal lung adenocarcinoma (WDFLAC) is a rare pulmonary carcinoma characterized by its resemblance to fetal lung. It is thought to be caused by somatic pathogenic variants (PVs) in the genes CTNNB1 or APC, which lead to the nuclear accumulation of beta(β)-catenin and down-stream activation of key oncogenes. Recent studies, however, have shown that germline and/or somatic PVs in DICER1 are also implicated in the etiology of lung tumors with fetal-type morphologies. Here, we report the second case of WDFLAC in a male non-smoker with familial adenomatous polyposis (FAP), and the first case with confirmed inactivating PVs in both APC and DICER1. A review of the literature also showed that out of the 17 WDFLAC cases for which sequencing of DICER1, CTNNB1 and/or APC was performed, 13 had PVs in DICER1 and either CTNNB1 or APC, with one patient having all three genes mutated. Taken together, this suggests that the development of WDFLAC may be the summative effect of WNT and DICER1 dysfunction. It may thus be beneficial to test for DICER1 variants in diagnostically challenging cases and, if a germline DICER1 PV is found, additional screening for DICER1-associated tumors could be pursued.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.